You are here

  • Home
  • Archive
  • Volume 9, Issue 11
  • Treatment-free survival over extended follow-up of patients with advanced melanoma treated with immune checkpoint inhibitors in CheckMate 067

Article metrics

Article menu
Clinical/translational cancer immunotherapy
Original research
Treatment-free survival over extended follow-up of patients with advanced melanoma treated with immune checkpoint inhibitors in CheckMate 067

 

Online download statistics by month:

Online download statistics by month: November 2021 to March 2024

AbstractFullPdf
Nov 2021457459355
Dec 2021396396182
Jan 2022227230136
Feb 202217117586
Mar 202218018683
Apr 202212112178
May 202212212449
Jun 202216116536
Jul 202210610644
Aug 202213714038
Sep 202211111141
Oct 202212512855
Nov 2022939346
Dec 2022858438
Jan 2023858956
Feb 202310610649
Mar 2023717338
Apr 2023565646
May 2023888854
Jun 2023687030
Jul 2023535332
Aug 2023484822
Sep 2023495012
Oct 2023404021
Nov 2023626232
Dec 2023545529
Jan 2024606133
Feb 2024434334
Mar 2024707282
Total344534841837